| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 37,156 | 37,336 | 40,512 | 59,443 | | Cost of Revenue | 16,957 | 17,538 | 18,415 | 24,741 | | | Gross Profit | 20,199 | 19,798 | 22,097 | 34,702 | | | Operating Expenses | | Research Development | 17,807 | 17,619 | 17,734 | 20,265 | | Selling General and Administrative | 17,222 | 12,678 | 13,715 | 16,866 | | Non Recurring | 348 | 7,098 | 19,969 | 3,982 | | Others | 1,473 | 1,473 | 1,473 | 1,587 | | | | Total Operating Expenses | 36,850 | 38,868 | 52,891 | 42,700 | | | | Operating Income or Loss | (16,651) | (19,070) | (30,794) | (7,998) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 696 | 598 | 939 | 1,151 | | Earnings Before Interest And Taxes | (15,955) | (18,472) | (29,855) | (6,847) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (15,955) | (18,472) | (29,855) | (6,847) | | Income Tax Expense | (444) | (5,143) | 3,474 | (11,860) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (15,511) | (13,329) | (33,329) | 5,013 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (15,511) | (13,329) | (33,329) | 5,013 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($15,511) | ($13,329) | ($33,329) | $5,013 |
|
0.24% Nasdaq 
0.08%
Income Statement
